NM_001364171.2:c.1097G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001364171.2(ODAD1):​c.1097G>A​(p.Arg366His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0328 in 1,613,962 control chromosomes in the GnomAD database, including 1,045 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R366C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.024 ( 65 hom., cov: 32)
Exomes 𝑓: 0.034 ( 980 hom. )

Consequence

ODAD1
NM_001364171.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.237

Publications

9 publications found
Variant links:
Genes affected
ODAD1 (HGNC:26560): (outer dynein arm docking complex subunit 1) This gene encodes a coiled-coil domain-containing protein that is a component of the outer dynein arm docking complex in cilia cells. Mutations in this gene may cause primary ciliary dyskinesia 20. [provided by RefSeq, May 2013]
ODAD1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 20
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003387034).
BP6
Variant 19-48302837-C-T is Benign according to our data. Variant chr19-48302837-C-T is described in ClinVar as Benign. ClinVar VariationId is 262510.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0242 (3692/152298) while in subpopulation NFE AF = 0.0365 (2481/68026). AF 95% confidence interval is 0.0353. There are 65 homozygotes in GnomAd4. There are 1742 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 65 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD1NM_001364171.2 linkc.1097G>A p.Arg366His missense_variant Exon 12 of 16 ENST00000674294.1 NP_001351100.1
ODAD1NM_144577.4 linkc.986G>A p.Arg329His missense_variant Exon 10 of 14 NP_653178.3 Q96M63-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD1ENST00000674294.1 linkc.1097G>A p.Arg366His missense_variant Exon 12 of 16 NM_001364171.2 ENSP00000501363.1 A0A6I8PTZ2

Frequencies

GnomAD3 genomes
AF:
0.0242
AC:
3687
AN:
152180
Hom.:
64
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00702
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0330
Gnomad ASJ
AF:
0.0173
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0110
Gnomad FIN
AF:
0.0173
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0365
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.0255
AC:
6395
AN:
250922
AF XY:
0.0251
show subpopulations
Gnomad AFR exome
AF:
0.00580
Gnomad AMR exome
AF:
0.0388
Gnomad ASJ exome
AF:
0.0193
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0180
Gnomad NFE exome
AF:
0.0344
Gnomad OTH exome
AF:
0.0250
GnomAD4 exome
AF:
0.0337
AC:
49224
AN:
1461664
Hom.:
980
Cov.:
34
AF XY:
0.0330
AC XY:
23996
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.00594
AC:
199
AN:
33480
American (AMR)
AF:
0.0406
AC:
1817
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
520
AN:
26120
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.00966
AC:
833
AN:
86258
European-Finnish (FIN)
AF:
0.0176
AC:
937
AN:
53306
Middle Eastern (MID)
AF:
0.00711
AC:
41
AN:
5768
European-Non Finnish (NFE)
AF:
0.0389
AC:
43254
AN:
1111930
Other (OTH)
AF:
0.0268
AC:
1618
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2689
5378
8066
10755
13444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1628
3256
4884
6512
8140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0242
AC:
3692
AN:
152298
Hom.:
65
Cov.:
32
AF XY:
0.0234
AC XY:
1742
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00700
AC:
291
AN:
41572
American (AMR)
AF:
0.0332
AC:
508
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
60
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.0112
AC:
54
AN:
4824
European-Finnish (FIN)
AF:
0.0173
AC:
184
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0365
AC:
2481
AN:
68026
Other (OTH)
AF:
0.0199
AC:
42
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
202
404
607
809
1011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0314
Hom.:
206
Bravo
AF:
0.0249
TwinsUK
AF:
0.0445
AC:
165
ALSPAC
AF:
0.0355
AC:
137
ESP6500AA
AF:
0.00704
AC:
31
ESP6500EA
AF:
0.0377
AC:
324
ExAC
AF:
0.0240
AC:
2915
Asia WGS
AF:
0.00779
AC:
27
AN:
3478
EpiCase
AF:
0.0302
EpiControl
AF:
0.0337

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 12, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
7.6
DANN
Benign
0.83
DEOGEN2
Benign
0.0015
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0048
N
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
-0.24
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.015
Sift
Benign
0.25
T
Sift4G
Benign
0.26
T
Polyphen
0.026
B
Vest4
0.081
MPC
0.31
ClinPred
0.015
T
GERP RS
-1.1
Varity_R
0.027
gMVP
0.12
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35361179; hg19: chr19-48806094; API